Literature DB >> 18563183

NOD/SCID repopulating cells contribute only to short-term repopulation in the baboon.

P Mezquita1, B C Beard, H-P Kiem.   

Abstract

We have previously compared the repopulation ability of gene-modified baboon CD34+ cells in an autologous transplantation versus a xenotransplant model in irradiated nonobese diabetic/severe combined immune deficiency (NOD/SCID) mice. Baboon CD34-selected marrow cells were transduced with a gammaretrovirus vector and infused into irradiated baboons and NOD/SCID mice. A limited integration-site analysis could only detect two common retrovirus integration sites in the NOD/SCID and monkey. Here, we performed locus-specific PCR on 30 clones recovered from NOD/SCID beta2-microglobulin mice reconstituted with transduced baboon CD34+ cells. We identified five common integrants in the baboon early after transplant (2-6 weeks) but none during the long-term follow-up (6 and 12 months). These results confirm that repopulating cells in the NOD/SCID mouse contribute only to short-term repopulation in a clinically relevant large animal model.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18563183     DOI: 10.1038/gt.2008.108

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  11 in total

1.  Transduction of human primitive repopulating hematopoietic cells with lentiviral vectors pseudotyped with various envelope proteins.

Authors:  Yoon-Sang Kim; Matthew M Wielgosz; Phillip Hargrove; Steven Kepes; John Gray; Derek A Persons; Arthur W Nienhuis
Journal:  Mol Ther       Date:  2010-04-06       Impact factor: 11.454

Review 2.  Center for fetal monkey gene transfer for heart, lung, and blood diseases: an NHLBI resource for the gene therapy community.

Authors:  Alice F Tarantal; Sonia I Skarlatos
Journal:  Hum Gene Ther       Date:  2012-10-19       Impact factor: 5.695

Review 3.  Gene Editing of Human Hematopoietic Stem and Progenitor Cells: Promise and Potential Hurdles.

Authors:  Kyung-Rok Yu; Hannah Natanson; Cynthia E Dunbar
Journal:  Hum Gene Ther       Date:  2016-08-02       Impact factor: 5.695

4.  Myeloid-lymphoid ontogeny in the rhesus monkey (Macaca mulatta).

Authors:  Cynthia A Batchelder; Nadire Duru; Charles I Lee; Chris A R Baker; Louise Swainson; Joseph M Mccune; Alice F Tarantal
Journal:  Anat Rec (Hoboken)       Date:  2014-05-28       Impact factor: 2.064

Review 5.  Large animal models of hematopoietic stem cell gene therapy.

Authors:  G D Trobridge; H-P Kiem
Journal:  Gene Ther       Date:  2010-04-29       Impact factor: 5.250

Review 6.  Pre-clinical modeling of CCR5 knockout in human hematopoietic stem cells by zinc finger nucleases using humanized mice.

Authors:  Ursula Hofer; Jill E Henley; Colin M Exline; Orla Mulhern; Evan Lopez; Paula M Cannon
Journal:  J Infect Dis       Date:  2013-11       Impact factor: 5.226

Review 7.  Ex vivo gene transfer and correction for cell-based therapies.

Authors:  Luigi Naldini
Journal:  Nat Rev Genet       Date:  2011-03-29       Impact factor: 53.242

Review 8.  Current translational and clinical practices in hematopoietic cell and gene therapy.

Authors:  David L Digiusto; Hans-Peter Kiem
Journal:  Cytotherapy       Date:  2012-08       Impact factor: 5.414

9.  Long-term vector integration site analysis following retroviral mediated gene transfer to hematopoietic stem cells for the treatment of HIV infection.

Authors:  Jun Hayakawa; Kareem Washington; Naoya Uchida; Oswald Phang; Elizabeth M Kang; Matthew M Hsieh; John F Tisdale
Journal:  PLoS One       Date:  2009-01-16       Impact factor: 3.240

10.  Foamy combinatorial anti-HIV vectors with MGMTP140K potently inhibit HIV-1 and SHIV replication and mediate selection in vivo.

Authors:  H-P Kiem; R A Wu; G Sun; D von Laer; J J Rossi; G D Trobridge
Journal:  Gene Ther       Date:  2009-09-10       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.